automated-news

BILL, Remitly, Marqeta Win Analyst Support As Fintech Growth Picks Up

Sage Kakkat

19 May 2025 — 1 min read

Last week, JP Morgan analyst Tien-tsin Huang hosted 17 payments and processing firms at its Global TMC Conference in Boston. Huang had an Overweight rating on BILL Holdings, Inc (NYSE:BILL) with a price target of $55 on Monday.Huang noted BILL as a category killer in SMB AP Automation, displacing manual and legacy solutions (including paper check processing).Also Read: Fiserv Delivers Solid Q1, Strong Margins And Client Wins, But Stock SlidesBILL was once a top growth name in Huang's FinTech coverage, and he sees paths to reclaim that status: cross-selling recent acquisitions, leveraging strong partnerships with banks and accountants, and helping SMBs cut costs through automation.Huang projected fourth-quarter revenue of $376 million and adjusted EPS of $0.41.Huang had an Overweight rating on Fiserv, Inc (NYSE:Full story available on Benzinga.com

Read Full Article →

Dum Dums lollipops stands by bright dyes, despite RFK Jr.’s push

The U.S. government is pushing food companies to switch their bright synthetic dyes to natural colors — but the maker of Dum Dums lollipops and Sweethearts candy hearts is in no rush. Read Full Article →

Crypto Firms Grapple With Bank-Like Risks, Without the Regulation

Crypto exchanges are rapidly evolving into digital-age banks, amassing vast troves of customer data and assets — but without the regulatory muscle or hardened security infrastructure of traditional finance. A recent breach at Coinbase, exposing sensitive user information through a social engineering attack, underscores the growing risk posed by centralized crypto

Top FDA Official Discloses She Never Received COVID-19 Vaccine

Top FDA Official Discloses She Never Received COVID-19 Vaccine Authored by Zachary Stieber via The Epoch Times (emphasis ours),A top Food and Drug Administration (FDA) official said on May 15 that she never took a COVID-19 vaccine due to concerns about biodistribution.Dr. Sara Brenner, the FDA’s principal

European stocks look set to build momentum after lackluster start to the week

This is CNBC’s live blog covering European markets.Good morning from London! Welcome to CNBC’s live blog covering European markets. Regional bourses are heading for a positive open Tuesday, looking to build some positive momentum after a muted trading session for equity markets on Monday.There are a

World Trade Flash